Nolan Sean P.

Director at DNA BRANDS INC · on record since Sep 24, 2021
Director at Ventas, Inc. · on record since May 15, 2026
EVP & CBO at INTERMUNE INC · on record since Aug 14, 2014
Director at Neurogene Inc. · on record since Feb 26, 2015
Director at AveXis, Inc. · on record since Feb 10, 2016
President & CEO at AveXis, Inc. · on record since Feb 10, 2016
Director at CAPRICOR THERAPEUTICS, INC. · on record since Oct 15, 2019
Director at Taysha Gene Therapies, Inc. · on record since Sep 30, 2020
Chief Executive Officer at Taysha Gene Therapies, Inc. · on record since Jan 4, 2023

Insider trading activity of Nolan Sean P.

Transactions on record: 91; since Mar 11, 2013

Open-market buys: 6; $430.7K

Open-market sells: 17; $5.6M

Companies traded: 6; last filing May 15, 2026

Figures computed from official regulatory filings — .

Companies where Nolan Sean P. has traded

Ventas, Inc.12 tx · $1M · May 15, 2026
Taysha Gene Therapies, Inc.19 tx · $1.3M · Jan 27, 2026
CAPRICOR THERAPEUTICS, INC.2 tx · May 7, 2020
AveXis, Inc.17 tx · $1.5M · May 15, 2018
Neurogene Inc.4 tx · May 9, 2018
INTERMUNE INC37 tx · $8.9M · Oct 1, 2014

Track record of Nolan Sean P.

Statistical track record

Free account

Open-market buys: 6

Last buy: Aug 16, 2023

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Nolan Sean P.

Co-insiders of Nolan Sean P.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Ventas, Inc.Listing on record	May 15, 2026	Award	2,047	90.35 USD	$184.9K		SEC
Ventas, Inc.Listing on record	Feb 17, 2026	Buy	36	27.70 USD	$997.2	conv 83First in 12mo	SEC
Ventas, Inc.Listing on record	Feb 17, 2026	Buy	50	27.70 USD	$1.4K	conv 83First in 12mo	SEC
Ventas, Inc.Listing on record	Feb 17, 2026	Buy	27	34.21 USD	$923.7	conv 54	SEC
Ventas, Inc.Listing on record	Feb 17, 2026	Buy	37	34.21 USD	$1.3K	conv 54	SEC
Taysha Gene Therapies, Inc.Listing on record	Jan 27, 2026	Sell	-41,312	4.61 USD	$190.4K		SEC
Taysha Gene Therapies, Inc.Listing on record	Jan 27, 2026	Sell	-136,789	4.75 USD	$649.7K		SEC
Taysha Gene Therapies, Inc.Listing on record	Jan 14, 2026	Award	1,008,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Taysha Gene Therapies, Inc.Listing on record	Jan 14, 2026	AwardD (derivative)	648,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ventas, Inc.Listing on record	May 15, 2025	Award	2,882	64.18 USD	$185K	Unusual size	SEC
Taysha Gene Therapies, Inc.Listing on record	Jan 3, 2025	AwardD (derivative)	892,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Taysha Gene Therapies, Inc.Listing on record	Jan 3, 2025	Award	892,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ventas, Inc.Listing on record	May 16, 2024	Award	3,648	47.96 USD	$175K	Unusual size	SEC
Taysha Gene Therapies, Inc.Listing on record	Jan 4, 2024	AwardD (derivative)	1,184,688	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Taysha Gene Therapies, Inc.Listing on record	Jan 4, 2024	Award	1,184,688	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Taysha Gene Therapies, Inc.Listing on record	Dec 18, 2023	AwardD (derivative)	466,550	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Taysha Gene Therapies, Inc.Listing on record	Aug 16, 2023	Buy	444,444	0.90 USD	$400K	conv 76ClusterUnusual size+1	SEC
Ventas, Inc.Listing on record	May 18, 2023	Award	3,835	45.63 USD	$175K	Unusual size	SEC
Taysha Gene Therapies, Inc.Listing on record	Jan 4, 2023	AwardD (derivative)	1,106,131	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Taysha Gene Therapies, Inc.Listing on record	Jun 22, 2022	AwardD (derivative)	15,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ventas, Inc.Listing on record	Apr 29, 2022	Award	3,056	57.25 USD	$175K	Unusual size	SEC
Taysha Gene Therapies, Inc.Listing on record	Jun 21, 2021	AwardD (derivative)	15,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ventas, Inc.Listing on record	May 27, 2021	Award	3,158	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Taysha Gene Therapies, Inc.Listing on record	May 24, 2021	Buy	1,170	22.35 USD	$26.1K	conv 82Unusual size	SEC
Taysha Gene Therapies, Inc.Listing on record	Sep 30, 2020	Other	1,089,500	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Ventas, Inc.Listing on record	May 15, 2026	Award	2,047	90.35 USD	$184.9K		SEC
Ventas, Inc.Listing on record	Feb 17, 2026	Buy	36	27.70 USD	$997.2	conv 83First in 12mo	SEC
Ventas, Inc.Listing on record	Feb 17, 2026	Buy	50	27.70 USD	$1.4K	conv 83First in 12mo	SEC
Ventas, Inc.Listing on record	Feb 17, 2026	Buy	27	34.21 USD	$923.7	conv 54	SEC
Ventas, Inc.Listing on record	Feb 17, 2026	Buy	37	34.21 USD	$1.3K	conv 54	SEC
Taysha Gene Therapies, Inc.Listing on record	Jan 27, 2026	Sell	-41,312	4.61 USD	$190.4K		SEC
Taysha Gene Therapies, Inc.Listing on record	Jan 27, 2026	Sell	-136,789	4.75 USD	$649.7K		SEC
Taysha Gene Therapies, Inc.Listing on record	Jan 14, 2026	Award	1,008,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Taysha Gene Therapies, Inc.Listing on record	Jan 14, 2026	AwardD (derivative)	648,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ventas, Inc.Listing on record	May 15, 2025	Award	2,882	64.18 USD	$185K	Unusual size	SEC
Taysha Gene Therapies, Inc.Listing on record	Jan 3, 2025	AwardD (derivative)	892,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Taysha Gene Therapies, Inc.Listing on record	Jan 3, 2025	Award	892,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ventas, Inc.Listing on record	May 16, 2024	Award	3,648	47.96 USD	$175K	Unusual size	SEC
Taysha Gene Therapies, Inc.Listing on record	Jan 4, 2024	AwardD (derivative)	1,184,688	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Taysha Gene Therapies, Inc.Listing on record	Jan 4, 2024	Award	1,184,688	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Taysha Gene Therapies, Inc.Listing on record	Dec 18, 2023	AwardD (derivative)	466,550	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Taysha Gene Therapies, Inc.Listing on record	Aug 16, 2023	Buy	444,444	0.90 USD	$400K	conv 76ClusterUnusual size+1	SEC
Ventas, Inc.Listing on record	May 18, 2023	Award	3,835	45.63 USD	$175K	Unusual size	SEC
Taysha Gene Therapies, Inc.Listing on record	Jan 4, 2023	AwardD (derivative)	1,106,131	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Taysha Gene Therapies, Inc.Listing on record	Jun 22, 2022	AwardD (derivative)	15,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ventas, Inc.Listing on record	Apr 29, 2022	Award	3,056	57.25 USD	$175K	Unusual size	SEC
Taysha Gene Therapies, Inc.Listing on record	Jun 21, 2021	AwardD (derivative)	15,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ventas, Inc.Listing on record	May 27, 2021	Award	3,158	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Taysha Gene Therapies, Inc.Listing on record	May 24, 2021	Buy	1,170	22.35 USD	$26.1K	conv 82Unusual size	SEC
Taysha Gene Therapies, Inc.Listing on record	Sep 30, 2020	Other	1,089,500	—	n/a (No price was disclosed in the filing)		SEC